Search company, investor...

Exsight

Founded Year

1993

Stage

Series B | Dead

Total Raised

$4.7M

Last Raised

$1.2M

About Exsight

Developer of non contact electrical testers (NCET) for printed circuit board (PCB) industry. The non contact electrical testers enable testing of very dense patterns at much higher speeds and lower testing costs. The NCET technology is based on generation of microscopic conductive plasma channel between the tip of the base probes and the pads.

Headquarters Location

Beit Tamar Tamar Park

Rehovot,

Israel

972 8 9466940

Missing: Exsight's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Exsight's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Exsight Frequently Asked Questions (FAQ)

  • When was Exsight founded?

    Exsight was founded in 1993.

  • Where is Exsight's headquarters?

    Exsight's headquarters is located at Beit Tamar, Rehovot.

  • What is Exsight's latest funding round?

    Exsight's latest funding round is Series B.

  • How much did Exsight raise?

    Exsight raised a total of $4.7M.

  • Who are the investors of Exsight?

    Investors of Exsight include Yozma Group, Sadot Venture Capital Management, TDA Capital Partners, Marathon, Evergreen Venture Partners and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.